Because these “disease awareness” campaigns are commonly linked to companies' marketing strategies, they operate to expand markets for new pharmaceutical products. Ostensibly engaged in raising public awareness about underdiagnosed and undertreated problems, these alliances tend to promote a view of their particular condition as widespread, serious, and treatable. Within many disease categories informal alliances have emerged, comprising drug company staff, doctors, and consumer groups. Whereas some aspects of medicalisation are the subject of ongoing debate, the mechanics of corporate backed disease mongering, and its impact on public consciousness, medical practice, human health, and national budgets, have attracted limited critical scrutiny. The social construction of illness is being replaced by the corporate construction of disease. 1, 2 Pharmaceutical companies are actively involved in sponsoring the definition of diseases and promoting them to both prescribers and consumers. Some forms of medicalising ordinary life may now be better described as disease mongering: widening the boundaries of treatable illness in order to expand markets for those who sell and deliver treatments. There's a lot of money to be made from telling healthy people they're sick.
#Trust company true parallels download how to#
Ray Moynihan, Iona Heath, and David Henry give examples of “disease mongering” and suggest how to prevent the growth of this practice
Pharmaceutical companies sponsor diseases and promote them to prescribers and consumers. A lot of money can be made from healthy people who believe they are sick.
0 kommentar(er)
